Evaluation of Cardiac CT Appropriateness at Second-generation 320-row CT

The influence of the second-generation 320-row area-detector CT (ADCT) on the clinical indications and appropriateness of cardiac CT has not been adequately investigated. The purpose of the survey is to assess the distribution of appropriateness ratings and test outcomes of cardiac CT with second-generation ADCT.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Coronary Artery Disease Arterial Occlusive Diseases Arteriosclerosis Cardiac CT Cardiovascular Diseases Coronary Disease Heart Diseases Myocardial Ischemia Vascular Diseases

Age range

20 year–90 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Kumamoto University

Kumamoto, 8608556, Japan

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

indicated for coronary CT assessment

Exclusion criteria

aortic disease
pulmonary embolism
severe arrhythmia
severe heart failure
allergy for iodinated contrast agent

Treatment and study plan

Primary outcomes

significant coronary stenosis

Time frame: one year

Sponsors and collaborators

Lead sponsor

Kumamoto University

Other

Registry information

Official study title

Evaluation of Cardiac CT Appropriateness at Second-generation 320-row CT With 0.275-sec Gantry Rotation Speed

Important dates

Study start: 2013
Primary completion: 2017
Study completion: 2017
First posted: Jan 13, 2014
Registry last updated: Aug 22, 2017

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed